there is another WSJ article by the same author that was put out last night titled, Placenta Products Maker MiMedx Draws FDA Attention The Question: Are its products, made by placenta, minimally manipulated. She goes on to say how 95% of the products the company makes are from placenta and fails to say only 15% of revenues are affected until the very end of the article. This Sara Germano author who wrote the WSJ piece last week doesn't even mention yesterday's company that received the same letter. Fair and balanced reporting!
The end of the article states: "Mr. Petit said that the company expects its amniotic injectable products to account for about 15% of its 2014 revenue. MiMedx reported revenue of $27.1 million for 2012, up nearly 250% from the year before."